Cargando…
The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
BACKGROUND: Rho-family GTPases, including Ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division control protein 42 (Cdc42), are important modulators of cancer-relevant cell functions and are viewed as promising therapeutic targets. Based on high-throughput screening and cheminformatics...
Autores principales: | Grimes, Martha M., Kenney, S. Ray, Dominguez, Dayna R., Brayer, Kathryn J., Guo, Yuna, Wandinger-Ness, Angela, Hudson, Laurie G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791840/ https://www.ncbi.nlm.nih.gov/pubmed/33413202 http://dx.doi.org/10.1186/s12885-020-07716-1 |
Ejemplares similares
-
Dual Actions of Ketorolac in Metastatic Ovarian Cancer
por: Hudson, Laurie G., et al.
Publicado: (2019) -
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases
por: Oprea, Tudor I., et al.
Publicado: (2015) -
Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
por: Steinkamp, Mara P., et al.
Publicado: (2023) -
Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis
por: Rivera, Melanie, et al.
Publicado: (2022) -
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
por: Hudson, Laurie G., et al.
Publicado: (2018)